The Clinical Spectrum of Benign Epilepsy with Centro-Temporal Spikes: a Challenge in Categorization and

Yun Jeong Lee1, Su Kyeong Hwang1, Soonhak Kwon1

  • 1Department of Pediatric Neurology, Kyungpook National University Children's Hospital, Kyungpook National University School of Medicine, Daegu, Korea.

Insights

Benign epilepsy with centro-temporal spikes (BECTS) in children may involve neuropsychological deficits, challenging its "benign" classification. These deficits depend on sleep and discharge location, suggesting a spectrum of childhood epilepsy disorders.

Area of Science:

  • Pediatric Neurology
  • Neurodevelopmental Disorders
  • Epileptology

Background:

  • Benign epilepsy with centro-temporal spikes (BECTS) is common in children, typically considered to have a good prognosis without neurological deficits.
  • However, emerging evidence links BECTS to various neuropsychological impairments, including linguistic, cognitive, and behavioral issues.

Purpose of the Study:

  • To re-evaluate the 'benign' nature of BECTS in light of potential neuropsychological deficits.
  • To explore the relationship between BECTS characteristics and cognitive/behavioral outcomes.

Main Methods:

  • Review of clinical and electroencephalographic (EEG) findings in BECTS patients.
  • Analysis of neurobiological studies on brain maturation and genetic susceptibility in childhood epilepsy.

Main Results:

  • BECTS can present with diverse clinical and EEG features associated with neuropsychological deficits.
  • The severity of deficits correlates with sleep cycles and the location of epileptiform discharges.
  • BECTS may represent a spectrum of childhood epilepsy disorders, including atypical forms and related encephalopathies.

Conclusions:

  • The traditional view of BECTS as entirely benign requires revision.
  • Clinical assessment should include evaluation for neuropsychological deficits, especially before treatment.
  • BECTS should be considered within a broader spectrum of childhood-onset epilepsy syndromes.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.8K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.0K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K